In PCa cell lines, we found that the pharmacological and genetic induction of HO-1 inhibits proliferation, migration, and invasion in vitro; further, it slows down tumor growth, limits tumor-associated angiogenesis [12] and neovascularization [15], and boosts the antitumor response in vivo [15]. Here, HMOX1 is linked to neoplasm.